The therapeutic use of colostrum-derived antibodies against toxin and spores of Clostridium difficile (#304)
Melanie L Hutton
1
,
Bliss Cunningham
1
,
Lucy Li
1
,
Anjana Chakravorty
1
,
Kate Mackin
1
,
Shelley Lyon
1
,
Edward Rose
1
,
Grant Rawlin
2
,
Julian Rood
1
,
Glen Carter
1
,
Dena Lyras
1
- Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC, Australia
- Immuron Ltd, Melbourne, VICTORIA, Australia